Game da kamfaninmuBayanin Maganin CAR-T
Alamomin CAR-T
● Cutar sankarar lymphoblastic mai tsanani ta B-cell
● Ciwon myeloma da yawa
● Ciwon sankarar lymphocytic na yau da kullun
● Ciwon sankarar lymphoid wanda ba Hodgkin ba
● Yaɗuwar babban ƙwayar cutar sankarar B-cell
● SLE (Tsarin Lupus Erythematosus)
Kyakkyawan aikin asibiti na CAR-T
Alamomi ga CD19+20CAR-T: Marasa lafiya da cutar lymphoma ba ta Hodgkin ba ta B-cell
Kudin CR na wata ɗaya | Kudin PR na wata ɗaya | Kudin wata ɗaya KO | CRS≥3 | CRES≥3 |
71.95%(59/82) | 25.6(21/82) | 97.55(80/82) | 12.19%(10/82) | 0 |
Alamomi ga CD19+22CAR-T: Maganin cutar sankarar jini ta B-lymphocytic da ta sake dawowa da kuma wadda ba ta da tabbas a cikin CD19
Kudin CR na wata ɗaya | Kudin PR na wata ɗaya | Kudin wata ɗaya KO | CRS≥3 | CRES≥3 |
92.1%(35/38) | Kashi 7.9%(3/38) | 100%(38/38) | Kashi 15.79%(6/38) | 0 |
Alamomi ga BCMACAR-T: Maganin sake dawowa da kuma rashin ƙarfin myeloma mai yawa
Kudin CR na wata ɗaya | Kudin PR na wata ɗaya | Kudin wata ɗaya KO | CRS≥3 | CRES≥3 |
72.41%(21/29) | 27.59%(8/29) | 100% (29/29) | Kashi 6.9%(2/29) | 0 |
Me Yasa Zabi Mu?
Amfaninmu
●Jiyya ta Musamman: Muna keɓance maganin CAR-T ga kowane majiyyaci, muna tabbatar da cewa an yi shi da kyau kuma yana da tasiri.
●Zaɓuɓɓukan Manufofi Mabanbanta: Kayayyakinmu na CAR-T suna ba da zaɓuɓɓuka iri-iri na manufa, gami da CD7, CD19, CD20, CD22, da BCMA, suna ba da fa'idar zaɓuɓɓukan magani na musamman ga marasa lafiya.
●Fasaha Mai Kyau: Maganinmu na CAR-T yana amfani da sabbin ci gaba a fannin injiniyan kwayoyin halitta da kuma maganin rigakafi.
●Ingantaccen farashi mai kyau: Idan aka kwatanta da sauran kayayyaki, muna bayar da daidaito mafi kyau tsakanin tabbatar da inganci da farashi mai kyau.
●Ƙwarewar Asibiti: Tare da goyon bayan ƙungiyar ƙwararrun likitoci da masu bincike, muna ba da kulawa mai inganci da tallafi a duk lokacin aikin jiyya.
●Cikakken Tsarin Kulawa: Muna bayar da cikakken kulawa, tun daga tantance marasa lafiya zuwa bayar da magani da kuma bin diddigin marasa lafiya, don tabbatar da samun sakamako mai kyau.
